Perioperative arginine-supplemented nutrition in malnourished patients with head and neck cancer improves long-term survival

American Journal of Clinical Nutrition

Volumn 92, Issue 5, 2010, Pages 1151-1156

  Buijs, Nikki ^a   Van Bokhorst De Van Der Schueren, Marian A E ^a   Langius, Jacqueline A E ^a   Leemans, C Rene ^a   Kuik, Dirk J ^a   Vermeulen, Mechteld A R ^a   Van Leeuwen, Paul A M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE;

ADULT; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE SEVERITY; DISTANT METASTASIS; DOUBLE BLIND PROCEDURE; ENTERIC FEEDING; FEMALE; HEAD AND NECK CANCER; HUMAN; MALE; MALNUTRITION; MORBIDITY; MORTALITY; NUTRITIONAL SUPPORT; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SECOND CANCER; TREATMENT OUTCOME; AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; HEAD AND NECK TUMOR; METASTASIS; MIDDLE AGED; RECURRENT DISEASE; SURVIVAL; TIME;

AGED; ARGININE; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; ENTERAL NUTRITION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MALNUTRITION; MIDDLE AGED; PERIOPERATIVE CARE; RECURRENCE; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 78149246871     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.2010.29532     Document Type: Article

References (43)

1. Brookes GB. Nutritional status - a prognostic indicator in head and neck cancer. Otolaryngol Head Neck Surg 1985;93:69-74.
2. Hussain M, Kish JA, Crane L, et al. The role of infection in the morbidity and mortality of patients with head and neck cancer undergoing multimodality therapy. Cancer 1991;67:716-21.
3. Preiser JC, Berre PJ, Van Gossum A, et al. Metabolic effects of arginine addition to the enteral feeding of critically ill patients. JPEN J Parenter Enteral Nutr 2001;25:182-7. (Pubitemid 32565857)
4. Sako K, Lore JM, Kaufman S, Razack MS, Bakamjian V, Reese P. Parenteral hyperalimentation in surgical patients with head and neck cancer: a randomized study. J Surg Oncol 1981;16:391-402. (Pubitemid 11156444)
5. Colasanto JM, Prasad P, Nash MA, Decker RH, Wilson LD. Nutritional support of patients undergoing radiation therapy for head and neck cancer. Oncology 2005;19:371-9 (Williston Park). (Pubitemid 350054579)
6. Jager-Wittenaar H, Dijkstra PU, Vissink A, van der Laan BF, van Oort RP, Roodenburg JL. Critical weight loss in head and neck cancer - prevalence and risk factors at diagnosis: an explorative study. Support Care Cancer 2007;15:1045-50.
7. Chiarla C, Giovannini I, Siegel JH. Plasma arginine correlations in trauma and sepsis. Amino Acids 2006;30:81-6.
8. Lind DS. Arginine and cancer. J Nutr 2004;134(suppl):2837S-41S.
9. Vissers YLJ, Dejong CHC, Luiking YC, Fearon KCH, von Meyenfeldt MF, Deutz NEP. Plasma arginine concentrations are reduced in cancer patients: evidence for arginine deficiency? Am J Clin Nutr 2005;81:1142-6.
10. Zea AH, Rodriguez PC, Atkins MB, et al. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res 2005;65:3044-8.
11. de Luis DA, Izaola O, Cuellar L, Terroba MC, Martin T, Aller R. Clinical and biochemical outcomes after a randomized trial with a high dose of enteral arginine formula in postsurgical head and neck cancer patients. Eur J Clin Nutr 2007;61:200-4. (Pubitemid 46251719)
12. de Luis DA, Izaola O, Cuellar L, Terroba MC, Martin T, Aller R. High dose of arginine enhanced enteral nutrition in postsurgical head and neck cancer patients. A randomized clinical trial. Eur Rev Med Pharmacol Sci 2009;13:279-83.
13. Stechmiller JK, Childress B, Porter T. Arginine immunonutrition in critically ill patients: a clinical dilemma. Am J Crit Care 2004;13:17-23.
14. Rodriguez PC, Quiceno DG, Ochoa AC. L-arginine availability regulates T-lymphocyte cell-cycle progression. Blood 2007;109:1568-73.
15. Marx J. Cancer immunology. Cancer's bulwark against immune attack: MDS cells. Science 2008;319:154-6.
16. Dimmeler S, Haendeler J, Nehls M, Zeiher AM. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J Exp Med 1997;185:601-7.
17. Bani D, Masini E, Bello MG, Bigazzi M, Sacchi TB. Relaxin activates the L-arginine-nitric oxide pathway in human breast cancer cells. Cancer Res 1995;55:5272-5.
18. van Bokhorst-de van der Schueren MAE, Quak JJ, von Blombergvan der Flier BME, et al. Effect of perioperative nutrition, with and without arginine supplementation, on nutritional status, immune function, post-operative morbidity, and survival in severely malnourished head and neck cancer patients. Am J Clin Nutr 2001;73:323-32.
19. Kurokawa H, Zhang M, Matsumoto S, et al. The high prognostic value of the histologic grade at the deep invasive front of tongue squamous cell carcinoma. J Oral Pathol Med 2005;34:329-33.
20. Thomas GR, Nadiminti H, Regalado J. Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma. Int J Exp Pathol 2005;86:347-63.
21. Popovic PJ, Zeh HJ, Ochoa JB. Arginine and immunity. J Nutr 2007;137 (suppl 2):1681S-6S.
22. Braga M, Gianotti L, Radaelli G, et al. Perioperative immunonutrition in patients undergoing cancer surgery: results of a randomized double-blind phase 3 trial. Arch Surg 1999;134:428-33.
23. Reilly JJ. Does nutrition management benefit the head and neck cancer patient? Oncology 1990;4:105-15.
24. Riso S, Aluffi P, Brugnani M, Farinetti F, Pia F, D'Andrea F. Post-operative enteral immunonutrition in head and neck cancer patients. Clin Nutr 2000;19:407-12.
25. van Bokhorst-de van der Schueren MAE, van Leeuwen PA, Kuik DJ, et al. The impact of nutritional status on the prognoses of patients with advanced head and neck cancer. Cancer 1999;86:519-27.
26. Bronte V, Serafini P, Mazzoni A, Segal DM, Zanovello P. L-arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends Immunol 2003;24:302-6.
27. Vermeulen MAR, van de Poll MCG, Ligthart-Melis GC, et al. Specific amino acids in the critically ill patient-exogenous glutamine/arginine: a common denominator? Crit Care Med 2007;35(suppl):S568-76.
28. Messmer UK, Ankarcrona M, Nicotera P, Brune B. p53 expression in nitric oxide-induced apoptosis. FEBS Lett 1994;355:23-6.
29. Nicotera P, Bonfoco E, Brune B. Mechanisms for nitric oxide-induced cell death: involvement of apoptosis. Adv Neuroimmunol 1995;5:411-20.
30. Brennan JA, Mao L, Hruban RH, et al. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 1995;332:429-35.
31. Liao CT, Chang JT-C, Wang HM, et al. Analysis of risk factors of predictive local tumor control in oral cavity cancer. Ann Surg Oncol 2008;15:915-22.
32. van Houten VM, Tabor MP, van den Brekel MW, et al. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer. J Pathol 2002;198:476-86.
33. Tabor MP, Brakenhoff RH, van Houten V, et al. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. Clin Cancer Res 2001;7:1523-32.
34. Kusmartsev S, Gabrilovich DI. Role of immature myeloid cells in mechanisms of immune evasion in cancer. Cancer Immunol Immunother 2006;55:237-45. (Pubitemid 41683212)
35. Capuano G, Rigamonti N, Grioni M, Freschi M, Bellone M. Modulators of arginine metabolism support cancer immunosurveillance. BMC Immunol 2009;10:1.
36. de Luis DA, Arranz M, Aller R, Izaola O, Cuellar L, Terroba MC. Immunoenhanced enteral nutrition, effect on inflammatory markers in head and neck cancer patients. Eur J Clin Nutr 2005;59:145-7.
37. Edwards PD, Topping D, KontaridisMI,Moldawer LL, Copeland EM, Lind DS. Arginine-enhanced enteral nutrition augments the growth of a nitric oxide-producing tumor. JPEN J Parenter Enteral Nutr 1997;21:215-9.
38. Park KG, Heys SD, Blessing K, et al. Stimulation of human breast cancers by dietary L-arginine. Clin Sci (Lond) 1992;82:413-7.
39. Loi C, Zazzo JF, Delpierre E, et al. Increasing plasma glutamine in postoperative patients fed an arginine-rich immune-enhancing diet - a pharmacokinetic randomized controlled study. Crit Care Med 2009;37:501-9.
40. Ascierto PA, Scala S, Castello G, et al. Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies. J Clin Oncol 2005;23:7660-8.
41. Weimann A, Braga M, Harsanyi L, et al. ESPEN guidelines on enteral nutrition: surgery including organ transplantation. Clin Nutr 2006;25:224-44.
42. Jones NE, Heyland DK. Pharmaconutrition: a new emerging paradigm. Curr Opin Gastroenterol 2008;24:215-22.
43. Ma Q, Wang Y, Gao X, Ma Z, Song Z. L-arginine reduces cell proliferation and ornithine decarboxylase activity in patients with colorectal adenoma and adenocarcinoma. Clin Cancer Res 2007;13:7407-12.